Name: Hadron Therapy Workshop: status and perspectives, plans for next generation facilities 18-19 October 2024
Start: 2024-10-18T08:00:00+02:00
End: 2024-10-19T23:30:00+02:00
Location: Zoom

Hadron Therapy Workshop: status and perspectives, plans for next generation facilities 18-19 October 2024

from Friday 18 October 2024 (08:00) to Saturday 19 October 2024 (23:30)

Monday 14 October 2024 ¶
Tuesday 15 October 2024 ¶
Wednesday 16 October 2024 ¶
Thursday 17 October 2024 ¶
Friday 18 October 2024 ¶
08:00
08:00 - 11:30
Contributions

08:00 Participants registration

08:45 Welcome Addresses

09:15 Historic and scientific evolution of Hadron Therapy - Ugo Amaldi (TERA Foundation (IT)) Sandro Rossi (CNAO)

09:35 Hadron Therapy in clinical practice - Sara Lillo (CNAO)

09:55 Radiobiology of Hadron Therapy - Angelica Facoetti (CNAO)

10:15 HITRIplus project, its impact on boosting research in South East Europe and future perspectives - Sanja Damjanovic (SEEIIST Association (CH) / GSI)

10:35 Building capacity through the IAEA programs - Sotirios Charisopoulos (IAEA)
11:30
11:30 - 15:00
Contributions

11:30 Hadron Therapy : from pioneering times towards the future - Manjit Dosanjh (University of Oxford (GB))

11:50 SEEIIST facility design and alternatives - Maurizio Vretenar (CERN)

12:10 CERN as an example of large scale infrastructure - Emmanuel Tsesmelis (CERN)

12:30 Status and vision of the SEEIIST project - Leandar Litov (University of Sofia - St. Kliment Ohridski (BG))

12:50 Concluding remarks - Roberto Orecchia (IEO)

13:00 Round table – SEEIIST towards to the Future
15:00 SESSION 3 – EXPERIENCES OF MULTIPARTICLE THERAPY FACILITIES IN OPERATION IN EUROPE
SESSION 3 – EXPERIENCES OF MULTIPARTICLE THERAPY FACILITIES IN OPERATION IN EUROPE
15:00 - 17:00
Contributions

15:00 Hadron Therapy at GSI - where we come from, where we go - Konrad Lehmann (GSI)

15:25 The HIT facility, technology, clinical applications and research: novel approaches in particle therapy - Andrea Mairani (HIT)

15:50 The Krakow Hadron Therapy facility, lessons learnt - Pawel Olko (IFJ - PAN)

16:15 Concluding remarks - Angelica Facoetti (CNAO)
17:00 SESSION 4 – ADVANCES IN ACCELERATOR TECHNOLOGIES FOR HADRON THERAPY FACILITIES
SESSION 4 – ADVANCES IN ACCELERATOR TECHNOLOGIES FOR HADRON THERAPY FACILITIES
17:00 - 22:20
Contributions

17:00 Accelerator and beam physics developments for medical and societal applications at CERN - Alessandra Lombardi (CERN)

17:20 Innovative gantry designs: Superconducting magnets for advanced gantry - Ernesto De Matteis (INFN)

17:35 Innovative gantry designs-continued - Ariel Haziot (CERN)

17:50 Optimisation for pre-injectors for hadron therapy-AM - Aristeidis Mamaras (Aristotle University of Thessaloniki / CERN)

18:10 An ion source project as a seed to build capacity for next generation accelerator physicists in Bosnia-and-Herzegovina - Amer Ajanovic (CERN/UNSA) Danis Bradaric (UNSA) Medina Dugonjic (UNSA) Naida Ustavdic (UNSA)

18:25 Development of the first table-top X-ray FLASH system - ELPIDA THEODORIDOU (DKFZ / Uni Malta) Joao Seco (DKFZ)

18:40 Concluding remarks - Laura Vallow (Mayo Clinic)

20:00 Welcome, Music event and Welcome Drink
Saturday 19 October 2024 ¶
09:00 Indications and clinical applications of HT
Indications and clinical applications of HT
09:00 - 11:30
Contributions

09:00 Chordoma treatments at CNAO - Maria Rosaria Fiore (CNAO)

09:25 Sarcoma treatments in Greece - Tasos Kyriazoglou (Attikon University Hospital)

09:45 Radiosurgery for Skullbase Meningiom - Christos Boskos (ST. LUKE'S)

10:05 SRS Treatment Planning for Endocranial Tumor - Anna Makridou

10:25 Personalization of hadron therapy for radioresistant cancers through bioindicators of radioresistance or conditional vulnerability - Michael Story (Mayo Clinic)

10:50 Concluding remarks - Arnold Pompos (UT Southwestern, Dallas, TX) Joao Seco (DKFZ)
11:30 SESSION 6 – SOCIO-ECONOMIC ASPECTS RELATED TO HADRON THERAPY
SESSION 6 – SOCIO-ECONOMIC ASPECTS RELATED TO HADRON THERAPY
11:30 - 15:00
Contributions

11:30 Hadrontherapy and EU clinical networks: status and perspectives - Lisa Licitra (CNAO, Uni Milan)

11:50 Costs of hadrontherapy, the ABC analysis applied to operations in CNAO - Maria Vittoria Livraga (CNAO)

12:10 Caring for cancer patients: the CNAO social approach - Silvia Meneghello (CNAO)

12:30 The role of citizens in innovating health - Katerina Zourou (Web2Learn) Stefania Oikonomou (Web2Learn)

12:45 The role of biomedical and clinical engineering societies in advancing and promoting Hadron Therapy on a national and international level - Alkinoos Athanasiou (AUTH, ELEVIT)

13:00 Challenges and Opportunities in the Patient's Pathway to Access - Menia Koukougianni (NGO KARKINAKI)

13:20 Empowering patient advocacy and cancer prevention - Panagiotis Bamidis (AUTH/AHEPA, ELEVIT)

13:35 Concluding remarks - Sandro Rossi (CNAO)
15:00 SESSION 7 – PEDIATRIC ONCOLOGY AND ROLE OF HADRON THERAPY
SESSION 7 – PEDIATRIC ONCOLOGY AND ROLE OF HADRON THERAPY
15:00 - 18:45
Contributions

15:00 Carbon Programme in MedAustron - Piero Fossati (MedAustron)

15:15 Pediatric Treatments in MedAustron - Carola Lütgendorf-Caucig (MedAustron)

15:30 Hadron therapy state-of-the art in pediatric oncology-clinical aspects - Sabina Vennarini (CNAO)

15:45 Treatment planning for pediatric cancer tumour treatments - Alfredo Mirandola (CNAO)

16:00 Pediatric brain tumour surgery : where do we stand? - Nikos Foroglou (AUTH/AHEPA)

16:15 Role of surgery in pediatric soft tissue sarcoma - Aikaterini Tzantzaroudi (Hippokration Hospital)

17:00 Panel discussion: Paediatric Oncology in Greece

17:01 Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit University Hospital AHEPA - Emmanouel Chatzipantelis (AUTH/AHEPA)

17:15 Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit Hospital Hippoktateio Hospital - Evgenia Papakonstantinou (Hippokrateio Hospital)

17:30 Pediatric patients commonly referred for external beam Radiotherapy - Antonio Capizzello (AUTH / AHEPA) Eftychia Tataridou (Theageneio Hospital)

17:45 The spectrum of pediatric patients referred for Protontherapy - Barbara Rombi (APSS - TRENTO)

18:00 Radiation treatment plan for pediatric cancer: a clinical view - George Giakoumetis (AUTH/AHEPA)

18:15 Concluding remarks - Semi Harrabi (HIT)

Choose timezone